News LifeArc rare disease programme to invest £100m improving pat... Self-funded, non-profit medical research organisation and charity LifeArc has announced today that it is to launch the Rare Disease Translational Challenge, which will inv
R&D AI could provide breakthrough for early diagnosis of rare di... For people living with rare diseases, one of the major challenges is being able to receive a rapid and accurate diagnosis.
R&D Sponsored Trials and tribulations of drug development: What does it ta... Rare diseases are a complex and challenging area of medicine, affecting millions of people worldwide.
R&D Making accessibility strategy part of your rare disease tria... Over the past several years, diversity, equity, and inclusion (DEI) has become a central subject of conversation in clinical trials.
Patients Challenges and opportunities with plasma-derived therapies This newest pharmaphorum podcast welcomes Takeda's Dr Kristina Allikmets.
R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.